Adiponectin as a biomarker in liver cirrhosis-A systematic review and meta-analysis  European Journal of Clinical Investigation. 2025;55(1):e14328
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39487742

Association between Sleep Duration and a New Onset of Nonalcoholic Fatty Liver Disease  Internal Medicine. 2024;63(24):3277-3282
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38658342

Cholesterol Crystal Embolism: Autopsy-proven Gastrointestinal Lesions, Pancreatitis, and End-stage Kidney Disease Which Developed after Undergoing Selective Abdominal Angiography  Internal Medicine. 2024;63(24):3325-3331
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38719599

Cure after surgery for hepato-pancreato-biliary cancers: A systematic review  Digestive and Liver Disease. 2025;57(1):1-7
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39004554

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study  Lancet. 2024;404(10470):2423-2436
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39581202

Facial recognition models for identifying genetic syndromes associated with pulmonary stenosis in children  Postgraduate Medical Journal. 2024;101(1191):37-44
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39075977

Genetic Polymorphism in Alcohol Metabolism and Drinking Behavior Are Associated with Gastric Cancer Risk in Men Internal Medicine. 2025;64(1):41-46
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38719602

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies  Lancet. 2025;405(10472):33-49
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39706209

How Would You Manage This Patient With Gastroesophageal Reflux Symptoms? Grand Rounds Discussion From Beth Israel Deaconess Medical Center  Annals of Internal Medicine. 2024;177(12):1695-1701
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39652874

Increased Risk of Chronic Respiratory Disease among Individuals with Inflammatory Bowel Disease in a Prospective Cohort Study  American Journal of Medicine. 2025;138(1):42-50.e5
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39370033

Large Language Models in Gastroenterology: Systematic Review  Journal of Medical Internet Research. 2024;26:e66648
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39705703

Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver Disease  Internal Medicine. 2025;64(1):47-54
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38719593

Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study  BMJ. 2024;387:e079147
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39653412

Non-pharmaceutical treatments for irritable bowel syndrome  BMJ. 2024;387:e075777
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39681399

Palliative pelvic radiotherapy for symptomatic frail or metastatic patients with rectal adenocarcinoma: A systematic review Digestive and Liver Disease. 2025;57(1):8-13
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39127573

Participation in the National Bowel Cancer Screening Program by people with severe mental illness, Australia, 2006-2019: a national data linkage study  Medical Journal of Australia. 2024;221(11):617-622
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39537556

Polyphenol Intervention Ameliorates Non-Alcoholic Fatty Liver Disease: An Updated Comprehensive Systematic Review  Nutrients. 2024;16(23)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39683546

Possible Case of Elderly-onset Intestinal Behçet's Disease with Trisomy 8 Following COVID-19 Vaccination Exacerbated by COVID-19 Infection  Internal Medicine. 2025;64(1):81-87
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39428534

Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis  Inflammatory Bowel Diseases. 2025;31(1):37-51
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38427714

Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease  Journal of Internal Medicine. 2025;297(1):47-59
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39560367

Sustained Clinical Complete Response after Discontinuation of Trastuzumab-deruxetecan Due to Interstitial Pneumonia for HER2-positive Gastric Adenocarcinoma with Enteroblastic Differentiation (GAED)  Internal Medicine. 2025;64(1):101-107
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38839335

Tumor Lysis Syndrome in a Patient with BRAF(V600E) Mutated Colon Cancer Treated with Cetuximab and Encorafenib  Internal Medicine. 2025;64(1):89-93
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38631859

Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Presenting with Transient Severe Fatty Liver and Subsequent Liver Dysfunction  Internal Medicine. 2024;63(24):3339-3344
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38719597

Weight and Muscle Mass Loss Associated with Acute Disease Can Be Reversed with Appropriate Nutrition Therapy and Exercise in a Patient with Amyotrophic Lateral Sclerosis  Internal Medicine. 2025;64(1):133-136
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38749729

Young Patient with X-linked Agammaglobulinemia Presents with Advanced Gastric Cancer and Extensive Atrophic Gastritis Internal Medicine. 2025;64(1):95-100
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38749732